Author Archives: admin


Can stem cells help mobility after stroke?

MIAMI - When Bruce Daily woke up after having lumbar surgery a year ago, he realized he couldn't move the right side of his body.

"It took me a long while to figure out I wasn't gonna walk again," he said. "I knew I was down."

Daily, 69, had gone in for lumbar surgery at the University of Miami hospital and had an ischemic stroke while under anesthesia. An ischemic stroke results from an obstruction in a blood vessel that blocks the blood from getting to the brain.

Because he was unconscious, he missed the four-to-five hour-window to apply the tissue plasminogen activator, or tPA, the only medication available to treat ischemic strokes. The medication dissolves the clot, restoring blood flow to the brain.

But while he missed that chance, he was right on time to meet Dr. Dileep Yavagal, a neurosurgeon who practices at the University of Miami and Jackson Memorial hospitals. Yavagal was enrolling patients in RECOVER-stroke, a clinical trial treating recent stroke patients with stem cells from their bone marrow and applying them directly into the carotid artery, one of two arteries that supply the neck and head with blood. Daily was one of 47 patients nationwide who qualified for the study.

The study is funded by Cytomedix, the company that developed the technology to extract stem cells from bone marrow. The firm chose Yavagal to lead a national blind study at the end of 2012.

Yavagal enrolled 13 patients at the University of Miami/Jackson Memorial Hospital, between the end of 2012 and January of 2014. So far, the initial three-month results have revealed that the marrow cells are not doing any damage, and there was no clear difference between those who received the cells and those who didn't. The study's one-year final results will be revealed in January.

"There is severe need for developing treatment for ischemic stroke, and stem cells are the most promising," said Yavagal, whose own research is still in its initial phase, focusing on using a healthy donor's bone marrow stem cells versus the patient's own marrow.

Stroke, the leading cause of adult disability in the United States, and the No. 4 cause of death in the country, causes 130,000 deaths a year in the U.S., according to the Centers for Disease Control and Prevention.

Yavagal, associate professor of clinical neurology and neurosurgery and the director of interventional neurology at the University of Miami's Miller School of Medicine, said that restricted mobility or loss of speech resulting from a moderate to severe stroke can be devastating because patients often become dependent on someone else for daily activities.

View post:
Can stem cells help mobility after stroke?

Iowa City-area research institute benefiting from ice bucket challenge

By Erin Jordan, The Gazette

IOWA CITY An Iowa City-area research institute has received donations from around the world as Catholic organizations encourage members to route their Ice Bucket Challenge gifts to an organization that doesnt do research on embryonic stem cells.

The John Paul II Medical Research Institute, founded in 2008 by Dr. Alan Moy, an Iowa City pulmonologist, has gotten hundreds of thousands of dollars in donations from people who want to support research on Amyotrophic Lateral Sclerosis (ALS), but dont want the research done with human embryos, said CEO Jay Kamath.

We serve as an alternative to them to donate money that aligns with their values, Kamath said Wednesday.

The non-profit institute, which employs three researchers at the University of Iowas BioVentures Center in Coralville, has developed a platform for research on adult stem cells, but so far hasnt done any studies on ALS, he said.

We havent had the funding streams, Kamath said.

But thats changing.

Donations have been pouring in since Catholic organizations, such as the Archdiocese of Cincinnati and Archdiocese of St. Louis, issued statements encouraging Catholics to donate money to the institute rather than the ALS Association, which started the Ice Bucket Challenge July 29.

The challenge asks people to post videos of themselves being doused with icy water and/or make a donation to an ALS charity. The ALS Association has so far raised more than $94 million from the drive.

The Archdiocese of Dubuque is the latest group to ask Catholics to steer donations to the John Paul II institute.

Read more here:
Iowa City-area research institute benefiting from ice bucket challenge

New Research Method Opens Door to Therapy with Human Muscle Stem Cells Promising Method Developed

27.08.2014 - (idw) Max-Delbrck-Centrum fr Molekulare Medizin (MDC) Berlin-Buch

Stem cells are essential for the repair of muscle damage, but all attempts to manipulate human muscle stem cells for therapy have thus far failed. Now Dr. Andreas Marg and Prof. Simone Spuler of the Experimental and Clinical Research Center (ECRC), a joint cooperation between the Max Delbrck Center (MDC) and the Charit, have shown how this might work. They developed a method in which they did not isolate the muscle stem cells, but rather cultivated, proliferated and transplanted them along with their muscle fibers. Using this method in mice, they were able to successfully regenerate muscle tissue. Thus they have opened the door for the use of muscle stem cells to treat muscle diseases.* "Muscle stem cells, which we also refer to as satellite cells, can awaken in their stem cell niche after decades of quiescence and can then repair damaged muscle tissue," Professor Spuler explained. At the ECRC in Berlin-Buch, the neurologist heads the University Outpatient Clinic for Muscle Disorders and the Department of Muscle Sciences. She and her team are exploring the causes of muscle diseases. Evidence shows that satellite cells are active in people with severe muscle diseases such as Duchenne muscular dystrophy, a severe genetic disease in which the muscles degenerate. "But at some point, she added, the reservoir is depleted of muscle stem cells and muscle wasting cannot be stopped."

All attempts to rebuild muscle tissue by transplanting satellite cells in patients with Duchenne muscular dystrophy have failed. The transplanted cells are not viable. Furthermore, the use of other cells with potential to regenerate muscle cells has shown little success. These cells have only limited potential to regenerate muscle. But how is it possible to nevertheless use the bodys own self-renewal potential and the reconstruction potential of satellite cells?

The offer of developmental biologist Professor Carmen Birchmeier (MDC) to participate in the network project on satellite cells (SatNet) of the Federal Ministry of Education and Research pointed Professor Spuler and her co-workers in the right direction. One of the topics of the project was to elucidate why satellite cells rapidly lose their regeneration potential if they are kept in a cell culture. This led to the idea to cultivate the satellite cells together with the surrounding muscle tissue to see whether the cells, if they remain in their accustomed milieu, might possibly regenerate better.

Muscle biopsy specimens from young and old donors After due approval and written, informed consent, Professor Spuler and Dr. Marg obtained specimens of fresh thigh muscle tissue from patients between 20 and 80 years of age from neurosurgeons of Helios Klinikum Berlin-Buch, which like the MDC is located close to the ECRC.

From the biopsy specimens, Professor Spuler and her co-workers dissected more than 1000 muscle fiber fragments, each about 2-3 millimeters long. Remarkably, the researchers found the number of stem cells in the individual tissue specimens to be independent of the age of the donor and that thousands of myoblasts developed from a small number of satellite cells. After further developmental steps, these fuse into muscle fibers.

Dr. Marg: Satellite cells need to have their local milieu around them Professor Spuler and her co-workers cultivated the muscle fiber fragments with the satellite cells, initially for up to three weeks. During this time, the satellite cells increased by 20- to 50-fold, but numerous connective tissue cells also developed in these cultures. To prevent this, the researchers concurrently subjected the muscle fragments to oxygen deprivation (hypoxia) and to cooling (hypothermia) at 4 degrees Celsius. Under these conditions, only satellite cells are able to survive in their stem cell niche, in contrast to the connective tissue cells. Apparently, the satellite cells receive the proper nutrients in their own local milieu, Dr. Marg said.

First success in mice The ECRC researchers then tried out their therapy approach in mice in which muscle regeneration had been inhibited by irradiation. They grafted the muscle fragments containing the satellite cells, which following the hypothermia had been kept for two weeks in culture dishes, into the tibalis anterior muscle. The researchers found that the muscles of animals that had been treated with these fiber fragments regenerated particularly well.

Objective: to couple satellite cells with gene therapy However, a genetic muscle disease cannot be successfully treated alone by transplanting muscle fragments. Professor Spuler: The idea is therefore to equip the satellite cells additionally with a healthy gene that repairs the defective gene and then to transfect it with the aid of a non-viral gene taxi into the muscles to be treated. In a first experiment with a reporter gene in the Petri dish, Professor Spuler and her co-workers proved that this is possible in principle. The reporter gene fluoresces green when it is transfected into the satellite cell. As gene taxi the researchers use the Sleeping Beauty transposon a jumping gene that can change its position in the genome. This transposon technique was developed several years ago by Dr. Zsuzsanna Izsvk (MDC) and Dr. Zoltn Ivics (Paul Ehrlich Institute, Frankfurt) and is considered to be a very promising delivery vehicle (vector) for gene therapy.

Before the method developed by Professor Spuler and her group can be used to benefit patients, some hurdles remain to be taken. So far, the transplantation has succeeded in small mice muscles. In clinical trials, the scientists and physicians want to determine whether this technique can be used in large human thigh muscles, which may be severely altered due to a muscular disease.

More here:
New Research Method Opens Door to Therapy with Human Muscle Stem Cells Promising Method Developed

2 Cases Suggest Stem Cell Transplant Might Ease 'Stiff Person' Syndrome

TUESDAY, Aug. 26, 2014 (HealthDay News) -- Two women with a rare disorder called stiff person syndrome recovered after receiving transplants of their own stem cells, a study shows.

Stiff person syndrome is rare neurological disease that causes stiffness of the skeletal muscles and painful muscle spasms. In severe cases, the disorder makes it difficult to move or walk.

Both of the women were treated in Canada by a team led by Dr. Sheilagh Sanders of the University of Ottawa.

Stem cell transplantation using a patient's own cells has been used successfully in patients with autoimmune diseases such as multiple sclerosis and scleroderma, the team noted. The treatment involves eliminating diseased immune cells and then regenerating the immune system with a person's own stem cells.

One of the women described in the new report began developing stiff person syndrome in 2005 when she was 48, the researchers said. She began suffering from progressively stiffer legs, overactive reflexes and frequent falling. The woman also, "walked with an abnormal 'tin soldier' gait," the team said.

Despite the use of medication, her condition got so bad that by late 2008 she was forced to quit work and had become "socially withdrawn."

Hoping to help, Sanders and her colleagues treated the woman in 2009 with transplanted stem cells taken from the patient's own body.

One month after the procedure, the patient no longer had symptoms and six months after the transplant she had returned to work and was playing sports.

Nearly five years later, the woman is still symptom-free, the team said.

The other woman was diagnosed with stiff person syndrome in 2008 at age 30, and had frequent spasms triggered by cold weather or stress. In the year prior to her stem cell transplant, she "made 47 emergency medical services calls with subsequent hospital visits and had required intensive care unit admission," Sanders' team said.

Read the original:
2 Cases Suggest Stem Cell Transplant Might Ease 'Stiff Person' Syndrome

Adult Stem Cell Public Lecture New York Manhattan Regenerative Medicine Medical Group

New York, California (PRWEB) August 28, 2014

The Manhattan Regenerative Medicine Medical Group announces a series of free public seminars on the use of adult stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief, and, Dr. Nia M. Smyrniotis, Medical Director.

The seminars will be held on Wednesday, September 3, 2014, at 2pm and 4pm at the City Limits Diner, at 135 Harvard Avenue, Stamford, CT 06902. Please RSVP at (917) 410-7391.

The Manhattan Regenerative Medicine Medical Group is an affiliate of the Miami Stem Cell Treatment Center, which abide by investigational protocols using adult adipose derived stem cells (ADSCs) which can be deployed to improve patients quality of life for a number of degenerative and chronic inflammatory conditions and diseases. ADSCs are taken from the patients own adipose (fat) tissue (found within a cellular mixture called stromal vascular fraction (SVF). ADSCs are exceptionally abundant in adipose tissue. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctors office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly adult autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity.

ADSCs are the body's natural healing cells - they are recruited by chemical signals emitted by damaged tissues to repair and regenerate the bodys injured cells. The Manhattan Regenerative Medicine Medical Group and the Miami Stem Cell Treatment Center only use Adult Autologous Stem Cells from a person's own fat No embryonic stem cells are used. Current areas of study include: Emphysema, COPD, Asthma, Heart Failure, Parkinsons Disease, Stroke, Multiple Sclerosis, Lupus, Rheumatoid Arthritis, Crohns Disease, and degenerative orthopedic joint conditions. For more information, or if someone thinks they may be a candidate for one of the adult stem cell protocols offered by the Manhattan Regenerative Medicine Medical Group or Miami Stem Cell Treatment Center, they may contact Dr. Gionis or Dr. Nia directly at (917) 410-7391, or see a complete list of the Centers study areas at: http://www.MiamiStemCellsUSA.com or http://www.NYStemCellsUSA.com.

About Manhattan Regenerative Medicine Medical Group and the Miami Stem Cell Treatment Center: The Manhattan Regenerative Medicine Medical Group and The Miami Stem Cell Treatment Center is an affiliate of the Cell Surgical Network (CSN); they are located in Manhattan, NY; Miami, Boca Raton, and Orlando, Florida. We provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. We utilize a fat transfer surgical technology to isolate and implant the patients own stem cells from a small quantity of fat harvested by a mini-liposuction on the same day. The investigational protocols utilized by the Manhattan Regenerative Medicine Medical Group and the Miami Stem Cell Treatment Center have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Health, Office of Human Research Protection; and the study is registered with Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information visit our website: http://www.MiamiStemCellsUSA.com or http://www.NYStemCellsUSA.com.

See the original post here:
Adult Stem Cell Public Lecture New York Manhattan Regenerative Medicine Medical Group

Fund efforts keep rolling

Aug. 27, 2014, noon

FUND-RAISING for Troy Eccleston's trip to Russia to receive life-changing stem cell treatment for multiple sclerosis continues.

Zoe Cairns, Taleah Cairns and Patrick Jennings have a blast at the Albion Park Youth and Community Care open day, which raised funds for Troy Eccleston's treatment. Picture: GEORGIA MATTS

FUND-RAISING for Troy Eccleston's trip to Russia to receive life-changing stem cell treatment for multiple sclerosis continues.

The Albion Park Rail resident is due to fly out in mid-September.

Meanwhile, several fund-raisers have been held, with the latest, a family open day at Albion Park Community Centre, successfully raising $1454.95 to go towards Troy's Treatment Fund.

To date more than $32,000 has been raised of the estimated $70,000 needed to cover his trip to Russia.

The next event will be at Albion Park Bowling Club on Friday, September 5, from 7pm and has been designed to be a fun night with music, games, auctions, psychic readings and finger food.

Cost is $30 and to book phone Cheryl on 0417 001 480.

Anyone unable to attend but wanting to donate can do so online at APYACC Troy's Treatment Fund BSB 802 124 Acc. No 100074208.

Go here to read the rest:
Fund efforts keep rolling

Canadian doctors use stem cells to treat 'stiff person syndrome'

Sheryl Ubelacker, The Canadian Press Published Tuesday, August 26, 2014 6:45AM EDT

TORONTO -- Canadian doctors have begun using stem cell transplants to treat "stiff person syndrome," a rare neurological condition in which a patient's leg and other muscles suddenly contract painfully, often leaving them immobilized like a tin soldier.

The disorder, which affects an estimated one in a million people, occurs when the immune system turns against a person's own tissues, in this case attacking cells in the brain and spinal cord.

Stem cell transplants have been used to treat patients with other auto-immune diseases, among them multiple sclerosis, scleroderma and Crohn's disease, but this may be the first time the procedure has been employed to alleviate the symptoms of stiff person syndrome, or SPS, the researchers reported Monday in the journal JAMA Neurology.

SPS is characterized by episodes of stiffness in the muscles and painful muscle spasms, which can be brought on by stress, loud noises or emotional distress. Some people with the disorder are so disabled they are unable to walk or move and may isolate themselves at home to avoid triggering an attack.

"Sometimes this happens when they're startled," said Dr. Harry Atkins of the Blood and Marrow Transplant Program at the Ottawa Hospital, who headed a team that transplanted stem cells into two women with the disease.

"So you can imagine walking across the street and someone honks the horn and you can't move, or you start falling and because your muscles can't move, you just fall and you hurt yourself," Atkins said Monday from Ottawa.

"It really does provide a barrier with just going on with your life."

Tina Ceroni of Toronto is one of the two SPS patients who had the stem-cell transplant -- and she said it has given back her life.

The personal fitness trainer, now 36, started getting severe symptoms in her late 20s. Initially she was diagnosed with hyponatremia, or low blood sodium, thought to be related to her heavy training schedule for a half-ironman competition.

Read more:
Canadian doctors use stem cells to treat 'stiff person syndrome'

Method developed to print replacement tissues using stem cells

Prof Frank Barry, scientific director of the Regenerative Medicine Institute at NUI Galway, with PhD student Babu Rajendra Prasad. Photograph: Joe OShaughnessy

By using tiny cartridges dispensing one stem cell at a time, Galway-based researchers may soon be able to literally print the scaffold of a healthy human tissue, and let it grow to become a therapeutic transplant.

When the Regenerative Medicine Institute at NUI Galway and Irish start-up company Poly-Pico Ltd recently joined forces for a trial proof-of-concept experiment, the results were spectacular.

They were able to dispense tiny drops from a cartridge filled with a stem cell mixture, each drop containing no more than a single stem cell.

Now imagine that we have five dispensing cartridges, each containing a different type of programmed stem cell, said Frank Barry, professor of cellular therapy and scientific director of the institute.

In principle we could essentially print them on to a surface and, by repeating the process a few thousands of times, obtain a mixture of growing cells and eventually a healthy pancreatic islet.

The islets produced by the printing process would then be transplanted into the pancreas of a Type 1 diabetic patient. The hope is that they will develop there and eventually help with the regulation of blood sugar levels.

It is a futuristic prospect, but it is not science fiction, Prof Barry said.

We are talking five years down the line for potential clinical trials.

In the experiment, the drops containing a single stem cell were easily identified and isolated. The cells were then allowed to replicate themselves into exact copies. Finally the researchers checked that they had remained viable and unaffected by the process.

More here:
Method developed to print replacement tissues using stem cells